ICRM
BIIB icon

Insight Capital Research & Management’s Biogen BIIB Stock Holding History

Insight Capital Research & Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-5,840
Closed -$2.36M – 92
2015
Q2 		$2.36M Sell
5,840
-6,741
-54% -$2.71M 0.62% 69
2015
Q1 		$5.31M Buy
12,581
+7,685
+157% +$3.03M 1.33% 21
2014
Q4 		$1.66M Sell
4,896
-7,625
-61% -$2.47M 0.43% 91
2014
Q3 		$4.14M Buy
+12,521
New +$4.13M 1.08% 41

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Insight Capital Research & Management's BIIB Position: Q3 2015 in Review

Insight Capital Research & Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 5,840 shares — an estimated $2.36M sold.

Insight Capital Research & Management first reported a position in BIIB in Q3 2014 and held it in 4 quarters. The position peaked at $5.31M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Insight Capital Research & Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Insight Capital Research & Management sold 5,840 Biogen shares in Q3 2015, an estimated $2.36M.
  • Insight Capital Research & Management first reported a position in Biogen in Q3 2014 and held it in 4 quarters.
  • Insight Capital Research & Management's Biogen position peaked at $5.31M in Q1 2015.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Insight Capital Research & Management's 13F filing for Q3 2015, filed 5 Nov 2015.